基本信息
浏览量:61
职业迁徙
个人简介
Avi (Avinash) is a multidisciplinary researcher with a diverse background in mathematics, engineering, statistics, and biology. Avinash's research has been widely recognized and has received several prestigious awards, including the Michelson Prize by the Human Vaccines Project, the K99 Young Investigator Award from the National Cancer Institute, and the Irving Foundation's recognition as one of the 40 most promising young Cancer Immunology scientists.
His research is situated at the intersection of data science and cancer immunology, where he is dedicated to developing artificial intelligence and probabilistic approaches that enable a systems-level understanding of tumor and immune microenvironments. Drawing on the cutting-edge research program he developed at Harvard, Avi's work has resulted in several critical discoveries, including the identification of bipotent drugs with dual anticancer potential, a new class of genetic interactions that drive response and resistance to cancer therapies, and Bayesian approaches for identifying genetic determinants of heart failure. Along with supervising a machine learning group of graduate students, Avi collaborates with several leading academic labs and pharmaceutical companies to develop new treatments for advanced cancer patients.
His research is situated at the intersection of data science and cancer immunology, where he is dedicated to developing artificial intelligence and probabilistic approaches that enable a systems-level understanding of tumor and immune microenvironments. Drawing on the cutting-edge research program he developed at Harvard, Avi's work has resulted in several critical discoveries, including the identification of bipotent drugs with dual anticancer potential, a new class of genetic interactions that drive response and resistance to cancer therapies, and Bayesian approaches for identifying genetic determinants of heart failure. Along with supervising a machine learning group of graduate students, Avi collaborates with several leading academic labs and pharmaceutical companies to develop new treatments for advanced cancer patients.
研究兴趣
论文共 68 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nishanth Ulhas Nair,Alejandro A Schäffer,E Michael Gertz,Kuoyuan Cheng,Johanna Zerbib,Avinash Das Sahu, Gil Leor, Eldad D Shulman,Kenneth D Aldape,Uri Ben-David,Eytan Ruppin
bioRxiv : the preprint server for biology (2024)
Journal of Translational Medicineno. 1 (2024): 1-16
Nishanth Ulhas Nair,Alejandro A. Schäffer, Michael E. Gertz,Kuoyuan Cheng,Avinash Das Sahu, Gil Leor, Eldad D. Shulman,Kenneth D. Aldape,Uri Ben-David, Eytan Ruppin
Cancer Researchno. 6_Supplement (2024): 2263-2263
Cancer Researchno. 6_Supplement (2024): 1523-1523
NATUREno. 7977 (2023): 188-+
引用1浏览0WOSNATURE引用
1
0
Lin Yang,Jin Wang,Jennifer Altreuter, Aashna Jhaveri, Cheryl J. Wong,Li Song,Jingxin Fu,Len Taing, Sudheshna Bodapati,Avinash Sahu,Collin Tokheim,Yi Zhang,
引用0浏览0WOSNATURE引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn